| Literature DB >> 28003850 |
Yanjie Wang1, Yu Zheng2, Shanshan Qu2, Jiping Zhang2, Zheng Zhong2, Jialing Zhang2, Huanlin Huang2, Miaokeng Li2, Yiwen Xu2, Junqi Chen3, Lei Wang4, Genevieve Zara Steiner5, Chunzhi Tang6, Yong Huang2.
Abstract
The study attempted to explore that the synergistic effect of acupoints combination is not a simple superposition of single acupoint's effect by comparing and analyzing the changes of blood pressure (BP), SF-36, and brain regions after acupuncture treatment. 47 patients were randomly divided into LR3+KI3 group, LR3 group, and KI3 group. Subjects received Rs-fMRI scan, BP measurement, and SF-36 questionnaires before and after treatment and short-term acupuncture treatment. After treatment, there were no significant differences in BP and SF-36 among 3 groups, compared to the case before treatment, SBP of 3 groups decreased, and DBP significantly decreased while vitality and mental health significantly increased in LR3+KI3 group. Both number and scopes of changes of brain regions in LR3+KI3 group were the largest, which mainly included BAs 3, 4, 8, 19, 21, 24, 32, 44, and 45. In conclusion, acupuncture at LR3+KI3 may auxiliarily reduce BP and improve the vitality and mental health of patients, and the changes of brain regions were related to somatesthesia, movement, vision, audition, emotion and mood, language, memory, etc. BAs 4, 9, 10, 24, 31, 32, and 46 may be the targeting brain areas of acupuncture in assisting hypotension. It is suggested that acupoints combination of LR3+KI3 maybe generates a synergistic effect, and it is not simple sum of single acupoint effect.Entities:
Year: 2016 PMID: 28003850 PMCID: PMC5149687 DOI: 10.1155/2016/5392954
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Flowchart of the participants.
Baseline characteristics ( or ).
| Characteristic | Group A | Group B | Group C | Statistical value |
| |
|---|---|---|---|---|---|---|
| Gender (%) | ||||||
| Male | 5 (33.33) | 1 (7.10) | 5 (33.33) |
| 0.174 | |
| Female | 10 (66.67) | 13 (92.90) | 10 (66.67) | |||
| Age (year) | 54.47 ± 7.13 | 56.29 ± 7.74 | 56.73 ± 5.12 |
| 0.529 | |
| Heredity (%) | ||||||
| Yes | 11 (73.3) | 8 (57.10) | 7 (46.70) |
| 0.327 | |
| No | 4 (26.70) | 6 (42.90) | 8 (53.30) | |||
| Course of disease (month) | 86.00 ± 52.30 | 78.93 ± 70.50 | 73.73 ± 45.15 |
| 0.482 | |
| SBP (mmHg) | 136.33 ± 17.43 | 134.93 ± 9.05 | 136.27 ± 14.16 |
| 0.956 | |
| DBP (mmHg) | 89.47 ± 8.43 | 86.29 ± 7.35 | 81.33 ± 9.16 |
| 0.377 | |
| SF-36 | PF | 88.33 ± 2.05 | 85.71 ± 3.39 | 92.67 ± 1.68 |
| 0.187 |
| RP | 70.00 ± 10.12 | 75.00 ± 9.81 | 70.00 ± 10.69 |
| 0.840 | |
| BP | 77.47 ± 3.66 | 79.07 ± 3.97 | 82.20 ± 4.37 |
| 0.549 | |
| GH | 54.47 ± 4.90 | 50.64 ± 3.76 | 60.53 ± 3.72 |
| 0.255 | |
| VT | 70.33 ± 4.77 | 68.21 ± 4.96 | 81.33 ± 2.91 |
| 0.082 | |
| SF | 85.93 ± 4.66 | 82.54 ± 4.15 | 84.44 ± 5.06 |
| 0.634 | |
| RE | 84.44 ± 7.88 | 73.81 ± 9.36 | 68.89 ± 10.01 |
| 0.453 | |
| MH | 69.60 ± 4.55 | 68.86 ± 4.00 | 78.00 ± 2.16 |
| 0.163 | |
Figure 2Flowchart of the experimental procedure. T1WI: T1-weighted image; fMRI: functional magnetic resonance imaging; BOLD: blood-oxygen-level dependent contrast; min: minutes.
Figure 3The location of LR3 and KI3.
Changes of average SBP and DBP of three groups between pretreatment and posttreatment ().
| Time | Items | Group A | Group B | Group C | Statistical value |
|
|---|---|---|---|---|---|---|
| BA | SBP (mmHg) | 136.33 ± 17.43 | 134.93 ± 9.05 | 136.27 ± 14.16 |
| 0.955 |
| DBP (mmHg) | 89.47 ± 8.43 | 86.29 ± 7.35 | 85.33 ± 9.16 |
| 0.268 | |
| AA | SBP (mmHg) | 130.00 ± 13.44 | 129.71 ± 8.66 | 133.60 ± 12.86 |
| 0.617 |
| DBP (mmHg) | 87.87 ± 5.04 | 86.71 ± 6.11 | 85.07 ± 7.29 |
| 0.470 |
BA: pretreatment; AA: posttreatment.
The changes of brain regions of group A after treatment versus before treatment.
| Number of voxels | Hemi | Brain areas | BA |
| Peak MNI coordinate | ||
|---|---|---|---|---|---|---|---|
|
|
|
| |||||
| 1248 | R | Inferior occipital gyrus | 19 | 5.8152 | 39 | −93 | −15 |
| 313 | L | Inferior frontal gyrus in triangular and opercular part | 44, 45 | 3.6219 | −9 | 60 | 18 |
| 366 | L | Postcentral gyrus, inferior parietal, excluding supramarginal and angular gyri, supramarginal gyrus | 3, 4 | 5.9703 | −45 | −27 | 42 |
| 344 | R | Insula, superior temporal gyrus | 21 | −5.0278 | 45 | −3 | −15 |
| 551 | R | Precuneus | — | −6.7036 | 12 | −60 | 42 |
| 851 | R | Anterior cingulate and paracingulate gyrus, median cingulate and paracingulate gyrus, medial superior frontal gyrus | 8, 24, 32 | −6.5526 | 6 | 12 | 27 |
Figure 4The changes of brain regions of group A after treatment versus before treatment. Note: the orange represents that the ReHo value increased; the blue means the ReHo value decreases.
The changes of brain regions of group B after treatment versus before treatment.
| Number of voxels | Hemi | Brain areas | BA |
| Peak MNI coordinate | ||
|---|---|---|---|---|---|---|---|
|
|
|
| |||||
| 91 | R | Parahippocampal gyrus, temporal pole (superior and middle temporal gyrus) | 28 | 4.5731 | 24 | 9 | −33 |
| 87 | R | Precuneus | 31 | 4.689 | 18 | −48 | 36 |
| 102 | L | Median cingulate and paracingulate gyrus | 24 | −4.5841 | −3 | 18 | 33 |
| 122 | R | Inferior parietal, excluding supramarginal and angular gyri, supramarginal gyrus | 40 | −4.1277 | 42 | −39 | 45 |
| 119 | L | Paracentral lobule | — | −3.717 | −6 | −24 | 48 |
Figure 5The changes of brain regions of group B after treatment versus before treatment.
The changes of brain regions of group C after treatment versus before treatment.
| Number of voxels | Hemi | Brain areas | BA |
| Peak MNI coordinate | ||
|---|---|---|---|---|---|---|---|
|
|
|
| |||||
| 100 | R | Postcentral gyrus | — | 3.8341 | 30 | −18 | 39 |
| 99 | L | Frontal lobe | — | 4.3742 | −30 | −15 | 39 |
| 167 | L | Putamen | — | −4.1377 | −21 | 6 | 12 |
Figure 6The changes of brain regions of group C after treatment versus before treatment.
The comparison of changes of brain regions among 3 groups after treatment.
| Number of voxels | Hemi | Brain areas | Brodmann area |
| Peak MNI coordinate | ||
|---|---|---|---|---|---|---|---|
|
|
|
| |||||
| Group A versus group B | |||||||
| 739 | R | Precuneus, median cingulate and paracingulate gyrus | 7, 31 | 4.8486 | 12 | −48 | −36 |
| 539 | R | Postcentral gyrus, paracentral lobule | 3, 5 | −5.545 | 15 | −39 | 72 |
|
| |||||||
| Group A versus group C | |||||||
| 120 | R | Superior and middle frontal gyrus | 9, 46 | 3.5548 | 21 | 42 | 48 |
| 98 | R | Medial superior frontal gyrus | 10 | 3.6219 | −9 | 60 | 18 |
|
| |||||||
| Group B versus group C | |||||||
| 377 | R | Middle frontal gyrus in orbital part | 46 | 5.5729 | 45 | 51 | −9 |
| 496 | R | Superior and middle occipital gyrus | 18, 19 | −4.3424 | 21 | −78 | 18 |
| 325 | R | Paracentral lobule | 4 | −4.0411 | 0 | −30 | 69 |
Figure 7The comparison of changes of brain regions among 3 groups after treatment.